Exact Mass: 497.25650708999996

Exact Mass Matches: 497.25650708999996

Found 500 metabolites which its exact mass value is equals to given mass value 497.25650708999996, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N1,N10-Diferuloylspermidine

(2Z)-N-{3-[(4-{[(2E)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}butyl)amino]propyl}-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidate

C27H35N3O6 (497.25257300000004)

N1,N10-Diferuloylspermidine is found in fruits. N1,N10-Diferuloylspermidine is an alkaloid from the pollen of Corylus avellana (filbert), also from Ananas comosus (pineapple) and Vicia faba. Alkaloid from the pollen of Corylus avellana (filbert), also from Ananas comosus (pineapple) and Vicia faba. N1,N10-Diferuloylspermidine is found in pulses, nuts, and fruits.

LysoPS(16:0/0:0)

(2S)-2-amino-3-({[(2R)-3-(hexadecanoyloxy)-2-hydroxypropoxy](hydroxy)phosphoryl}oxy)propanoic acid

C22H44NO9P (497.2753544)

LysoPS(16:0/0:0) is a lysophosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylserines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPS(16:0/0:0), in particular, consists of one chain of palmitic acid at the C-1 position.

2'-Methyl-4'-(5-methyl-(1,2,4)-oxadiazol-3-yl)biphenyl-4-carboxylic acid (4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)amide

2-Methyl-4-(5-methyl-(1,2,4)-oxadiazol-3-yl)biphenyl-4-carboxylic acid (4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)amide

C29H31N5O3 (497.2426776)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

2-((4R)-4-((3R,5S,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

"2-((4R)-4-((3R,5S,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid"

C26H43NO6S (497.28109380000006)

Ala Asp His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C19H31N9O7 (497.2346336)

Ala Asp Arg His

(3S)-3-[(2S)-2-aminopropanamido]-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butyl]carbamoyl}propanoic acid

C19H31N9O7 (497.2346336)

Ala His Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C19H31N9O7 (497.2346336)

Ala His Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]butanedioic acid

C19H31N9O7 (497.2346336)

Ala Arg Asp His

(3S)-3-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C19H31N9O7 (497.2346336)

Ala Arg His Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]butanedioic acid

C19H31N9O7 (497.2346336)

Cys Phe Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]hexanamido]-3-hydroxybutanoic acid

C22H35N5O6S (497.23079300000006)

Cys Phe Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-hydroxybutanamido]hexanoic acid

C22H35N5O6S (497.23079300000006)

Cys Lys Phe Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-phenylpropanamido]-3-hydroxybutanoic acid

C22H35N5O6S (497.23079300000006)

Cys Lys Thr Phe

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-hydroxybutanamido]-3-phenylpropanoic acid

C22H35N5O6S (497.23079300000006)

Cys Thr Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-phenylpropanamido]hexanoic acid

C22H35N5O6S (497.23079300000006)

Cys Thr Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]hexanamido]-3-phenylpropanoic acid

C22H35N5O6S (497.23079300000006)

Asp Ala His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C19H31N9O7 (497.2346336)

Asp Ala Arg His

(3S)-3-amino-3-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C19H31N9O7 (497.2346336)

Asp His Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-5-carbamimidamidopentanoic acid

C19H31N9O7 (497.2346336)

Asp His Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-methylbutanoic acid